Applied Genetic Technologies Corp. appointed opthamologist Dr. Matthew Feinsod its interim CMO.
Here's what you should know:
1. Dr. Feinsod previously served as the company's product development officer.
2. He succeeds Michael Goldstein, MD, who left the company to pursue other opportunities.
3. Dr. Feinsod holds several ophthalmology-based patents. He has also founded several companies, including Imagen Biotech, a company developing ophthalmology treatments for the unmet needs of those suffering from sight-threatening diseases.
4. Dr. Feinsod will be supported by the company's clinical team.